Facebook: Analysts Expect $3.03 In Q2 Earnings Per Share

Facebook (NASDAQ: FB) will be reporting its second quarter financial results today after the markets close. Analysts have a consensus $391.39 12-month price target on the company, via a total of 55 analysts, with 19 analysts having strong buy ratings. 27 analysts meanwhile have buy ratings, 7 have hold ratings, and two analysts have sell ratings on the company. The street high comes from Credit Suisse with a $480 price target, and the lowest target sits at $225 from Societe Generale.

38 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 38 analysts is $27.87 billion; this number has been revised upwards from $24.28 billion at the start of the year. The highest revenue estimate is $28.75 billion, while the lowest is $27 billion.

Onto EBITDA estimates, there are currently 25 analysts who have second-quarter EBITDA estimates. The mean is currently $14.48 billion, with this number having been revised upwards from $11.78 billion at the start of the year. The street high estimate currently sits at $15.59 billion in EBITDA and the lowest is $12.36 billion.

Analysts estimate that quarterly earnings per share will come in at $3.03, with this number being revised upwards from $2.31 at the start of the year. Street high is $3.41 and the lowest estimate is $2.36 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A $3 Billion Gold Deal Just Changed the Market | G Mining Acquires G2 Goldfields

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Recommended

Total Metals Secures High Grade Critical Minerals Property In Northwestern Ontario

Discovery at Luis Hill Prompts Acceleration of Phase 2 Program for Questcorp

Related News

Small Pharma: Canaccord Initiates Coverage With $1.00 Price Target

Canaccord Genuity recently initiated coverage on Small Pharma Inc (TSXV: DMT), a company that is...

Sunday, June 13, 2021, 01:08:00 PM

Enthusiast Gaming Sees Canaccord Give Slight Lift To Price Target

On May 16th, Enthusiast Gaming (TSX: EGLX) reported its first quarter financial results. The company...

Sunday, May 22, 2022, 05:19:00 PM

Acreage Holdings: Analyst Q1 2020 Estimates

Tomorrow, Acreage Holdings (CSE: ACRG.u) reports their first quarter 2020 financials after the close of...

Wednesday, June 24, 2020, 06:28:22 PM

ReconAfrica: Haywood Resumes Coverage With $12.50 Price Target

On May 17th, ReconAfrica (CVE: RECO) announced that they closed a C$41.4 million bought deal....

Monday, May 31, 2021, 03:56:00 PM

Trump is Back! Meta Restores Former President’s Facebook Account

Donald Trump’s Facebook and Instagram accounts have been restored, allowing the former president to post...

Saturday, February 11, 2023, 11:19:00 AM